re: morphosys news "With all due respect Tony, PYC's technology or peptides cannot do either of the two things you suggested. They have no data showing that their peptides can cross cells and be active"
BioE: The following link gives PYCs CPP data that they are comfortable sharing.
http://www.phylogica.com/media/PhylogicaTechnicalMay2012.pdf
I'd presume Janssen and the other pharma partners have seen additional comprehensive data.
re: morphosys news "With all due respect Tony, PYC's technology...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.45 |
Change
-0.005(0.34%) |
Mkt cap ! $842.8M | |||
| Open | High | Low | Value | Volume |
| $1.45 | $1.46 | $1.40 | $451.6K | 315.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10001 | $1.43 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.45 | 3114 | 1 |
View Market Depth
| Last trade - 16.10pm 08/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |